Invivo Therapeutics Holdings Corp.
NVIVDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001292519
Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Invivo Therapeutics Holdings Corp. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 16 | 17 | +1 |
| Shares | 164.2K | 306.0K | +141.8K (+86.4%) |
| Value | $703.0K | $718.7K | +$15.7K (+2.2%) |
New holders (4)
Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 222,000 | $521.7K | 0.01% |
| Colonial Trust Advisors | 2 | $5 | 0.00% |
| Farther Finance Advisors, LLC | 2 | $5 | 0.00% |
| JPMorgan Chase & Co | 1 | $0 | 0.00% |
Sold out (3)
Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Citadel Advisors LLC | 42,794 | $184.0K |
| Two Sigma Investments, LP | 11,521 | $49.0K |
| Two Sigma Advisers, LP | 10,468 | $45.0K |